Answers are grounded in this paper and cite their sources.
Naringenin is a naturally occurring flavanone with antioxidant, anti-inflammatory and anticancer potential; however, its practical pharmaceutical application is constrained by poor aqueous solubility and limited oral bioavailability. The present work investigated the preparation and characterization of naringenin-loaded zinc oxide (ZnO) nanoparticles as a nanoenabled approach for improving the physicochemical and dissolution characteristics of naringenin. ZnO nanoparticles were prepared by a precipitation method using zinc acetate dihydrate as the zinc precursor and sodium hydroxide as the precipitating agent. The zinc precursor solution was treated with NaOH under continuous stirring, followed by heating, centrifugation, washing and drying. Naringenin was subsequently loaded onto the prepared ZnO nanoparticles at drug-tonanoparticle ratios of 1:20, 1:10 and 1:5. Tween 80 was used as a stabilizer during loading. Naringenin was authenticated by appearance, melting point and spectroscopic methods. UV-visible analysis showed a maximum absorption at 289 nm in methanol, with linearity over 2–16 µg/mL and a regression equation of y = 0.0825x − 0.1279 (R² = 0.9982). The aqueous solubility of naringenin-loaded nanoparticles was 186.55 ± 0.21 µg/mL compared with 34.65 ± 0.29 µg/mL for pure naringenin and 47.24 ± 0.24 µg/mL for the physical mixture. The nanoparticle formulation produced 93.16 ± 2.06% cumulative drug release at 12 h, whereas pure naringenin and the physical mixture showed 32.71 ± 0.51% and 42.74 ± 1.14%, respectively. The reported optimized nanoparticle exhibited a particle size of 143.2 ± 5.6 nm, PDI of 0.270 ± 0.07 and zeta potential of −40.0 ± 0.4 mV. FTIR findings indicated retention of characteristic naringenin functional groups with slight shifts and reduced intensity, while XRD confirmed the crystalline ZnO structure and successful loading without evident impurity peaks. Overall, the findings demonstrate that ZnO nanoparticle loading markedly improved naringenin solubility and in-vitro dissolution performance, supporting further investigation of this system as a potential nano-drug delivery platform.
No takes yet. Share an insight, caveat, or question.
Metkari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: